Fundraising Fox

Jupiter Biomedical Research

Palm Beach Gardens, US · Founded 2016 · Florida corporation

Jupiter Biomedical Research develops two drug candidates: JBR-102, a new chemical entity in preclinical studies for glioblastoma and other solid tumor and hematologic cancers, and JBR-201, an antiviral therapeutic tested against measles, herpes, and other viruses. The company focuses on commercializing these oncology and antiviral treatments.

Founders & leadership

RC
Robert C. HackneyExecutive
RP
Richard P. TamboneExecutive
FG
Frank GerardiExecutive
RT
Richard TamboneExecutive
CH
Charles H. BurnsExecutive
JF
John FanarasNamed on SEC filing
WG
William G. TuckerNamed on SEC filing
VT
Vivian TuckerNamed on SEC filing

Board

TS
Tipton ShonkwilerBoard director

Reported raises · per SEC filings

Form D private placements

$2.1M disclosed across 4 rounds · 2017–2026

$500KraisedMay 2026 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tipton ShonkwilerDirector
  • David VaughanDirector
  • Robert C. HackneyExecutive Officer, Director
  • Frank GerardiExecutive Officer, Director
  • John FanarasExecutive Officer, Director
  • Richard P. TamboneExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
Minimum investment
$5K
First sale
Feb 2026
Incorporated
Corporation, Florida
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
$500KraisedNov 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John FanarasExecutive Officer, Director
  • Robert C. HackneyExecutive Officer, Director
  • Tipton ShonkwilerDirector
  • Richard P. TamboneExecutive Officer, Director
  • Frank GerardiExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
Minimum investment
$5K
First sale
Jun 2025
Incorporated
Corporation, Florida
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
$625KraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank GerardiExecutive Officer, Director, Promoter
  • William G. TuckerExecutive Officer, Director, Promoter
  • Richard P. TamboneExecutive Officer, Director, Promoter
  • Kingsley WardDirector
  • John FanarasDirector
  • Robert C. HackneyDirector
  • Charles H. BurnsExecutive Officer, Director, Promoter
Amount sold
$625K
Minimum investment
$25K
First sale
Oct 2020
Incorporated
Corporation, Florida, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$500KraisedApr 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank GerardiDirector
  • William G. TuckerExecutive Officer, Director, Promoter
  • Richard TamboneExecutive Officer, Director
  • Charles H. BurnsExecutive Officer, Director
  • Vivian TuckerExecutive Officer, Director, Promoter
Offering amount
$500K
Amount sold
$500K
Minimum investment
$50K
Proceeds to insiders
$100K
First sale
Jan 2017
Incorporated
Corporation, Florida, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Jupiter Biomedical Research for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Jupiter Biomedical Research do?
Jupiter Biomedical Research develops two drug candidates: JBR-102, a new chemical entity in preclinical studies for glioblastoma and other solid tumor and hematologic cancers, and JBR-201, an antiviral therapeutic tested against measles, herpes, and other viruses. The company focuses on commercializing these oncology and antiviral treatments.
How much funding has Jupiter Biomedical Research raised?
Jupiter Biomedical Research has disclosed $2.1M raised across 4 rounds.
Where is Jupiter Biomedical Research headquartered?
Jupiter Biomedical Research is headquartered in Palm Beach Gardens, US.